179 related articles for article (PubMed ID: 25435337)
1. Plasma levels of progranulin and interleukin-6 in frontotemporal lobar degeneration.
Gibbons L; Rollinson S; Thompson JC; Robinson A; Davidson YS; Richardson A; Neary D; Pickering-Brown SM; Snowden JS; Mann DM
Neurobiol Aging; 2015 Mar; 36(3):1603.e1-4. PubMed ID: 25435337
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration.
Goossens J; Bjerke M; Van Mossevelde S; Van den Bossche T; Goeman J; De Vil B; Sieben A; Martin JJ; Cras P; De Deyn PP; Van Broeckhoven C; van der Zee J; Engelborghs S
Alzheimers Res Ther; 2018 Mar; 10(1):31. PubMed ID: 29559004
[TBL] [Abstract][Full Text] [Related]
3. Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort.
Antonell A; Gil S; Sánchez-Valle R; Balasa M; Bosch B; Prat MC; Chiollaz AC; Fernández M; Yagüe J; Molinuevo JL; Lladó A
J Alzheimers Dis; 2012; 31(3):581-91. PubMed ID: 22647257
[TBL] [Abstract][Full Text] [Related]
4. Plasma progranulin levels in cortical dementia phenotypes with asymmetric perisylvian atrophy.
Gómez-Tortosa E; Guerrero-López R; Gil-Neciga E; Franco E; del Ser T; Jiménez Escrig A; Pérez-Pérez J; Sainz MJ
Eur J Neurol; 2013 Sep; 20(9):1319-24. PubMed ID: 23724906
[TBL] [Abstract][Full Text] [Related]
5. Association of the variant Cys139Arg at GRN gene to the clinical spectrum of frontotemporal lobar degeneration.
Piaceri I; Pradella S; Cupidi C; Nannucci S; Polito C; Bagnoli S; Tedde A; Smirne N; Anfossi M; Gallo M; Bernardi L; Colao R; Maletta R; Bruni AC; Sorbi S; Nacmias B
J Alzheimers Dis; 2014; 40(3):679-85. PubMed ID: 24503614
[TBL] [Abstract][Full Text] [Related]
6. Elevated TMEM106B levels exaggerate lipofuscin accumulation and lysosomal dysfunction in aged mice with progranulin deficiency.
Zhou X; Sun L; Brady OA; Murphy KA; Hu F
Acta Neuropathol Commun; 2017 Jan; 5(1):9. PubMed ID: 28126008
[TBL] [Abstract][Full Text] [Related]
7. Role of progranulin as a biomarker for Alzheimer's disease.
Sleegers K; Brouwers N; Van Broeckhoven C
Biomark Med; 2010 Feb; 4(1):37-50. PubMed ID: 20387302
[TBL] [Abstract][Full Text] [Related]
8. Disease and Region Specificity of Granulin Immunopositivities in Alzheimer Disease and Frontotemporal Lobar Degeneration.
Mao Q; Wang D; Li Y; Kohler M; Wilson J; Parton Z; Shmaltsuyeva B; Gursel D; Rademakers R; Weintraub S; Mesulam MM; Xia H; Bigio EH
J Neuropathol Exp Neurol; 2017 Nov; 76(11):957-968. PubMed ID: 29044416
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid biomarkers in Progranulin mutations carriers.
Carecchio M; Fenoglio C; Cortini F; Comi C; Benussi L; Ghidoni R; Borroni B; De Riz M; Serpente M; Cantoni C; Franceschi M; Albertini V; Monaco F; Rainero I; Binetti G; Padovani A; Bresolin N; Scarpini E; Galimberti D
J Alzheimers Dis; 2011; 27(4):781-90. PubMed ID: 21891865
[TBL] [Abstract][Full Text] [Related]
10. Progranulin genetic screening in frontotemporal lobar degeneration patients from central Italy.
Bagnoli S; Piaceri I; Tedde A; Piacentini S; Nannucci S; Bracco L; Sorbi S; Nacmias B
Cell Mol Neurobiol; 2012 Jan; 32(1):13-6. PubMed ID: 21800185
[TBL] [Abstract][Full Text] [Related]
11. Novel progranulin mutations with reduced serum-progranulin levels in frontotemporal lobar degeneration.
Chiang HH; Forsell C; Lilius L; Öijerstedt L; Thordardottir S; Shanmugarajan K; Westerlund M; Nennesmo I; Thonberg H; Graff C
Eur J Hum Genet; 2013 Nov; 21(11):1260-5. PubMed ID: 23463024
[TBL] [Abstract][Full Text] [Related]
12. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members.
Finch N; Baker M; Crook R; Swanson K; Kuntz K; Surtees R; Bisceglio G; Rovelet-Lecrux A; Boeve B; Petersen RC; Dickson DW; Younkin SG; Deramecourt V; Crook J; Graff-Radford NR; Rademakers R
Brain; 2009 Mar; 132(Pt 3):583-91. PubMed ID: 19158106
[TBL] [Abstract][Full Text] [Related]
13. TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers.
Finch N; Carrasquillo MM; Baker M; Rutherford NJ; Coppola G; Dejesus-Hernandez M; Crook R; Hunter T; Ghidoni R; Benussi L; Crook J; Finger E; Hantanpaa KJ; Karydas AM; Sengdy P; Gonzalez J; Seeley WW; Johnson N; Beach TG; Mesulam M; Forloni G; Kertesz A; Knopman DS; Uitti R; White CL; Caselli R; Lippa C; Bigio EH; Wszolek ZK; Binetti G; Mackenzie IR; Miller BL; Boeve BF; Younkin SG; Dickson DW; Petersen RC; Graff-Radford NR; Geschwind DH; Rademakers R
Neurology; 2011 Feb; 76(5):467-74. PubMed ID: 21178100
[TBL] [Abstract][Full Text] [Related]
14. Portuguese family with the co-occurrence of frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis phenotypes due to progranulin gene mutation.
Almeida MR; Macário MC; Ramos L; Baldeiras I; Ribeiro MH; Santana I
Neurobiol Aging; 2016 May; 41():200.e1-200.e5. PubMed ID: 27021778
[TBL] [Abstract][Full Text] [Related]
15. Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease.
Carecchio M; Fenoglio C; De Riz M; Guidi I; Comi C; Cortini F; Venturelli E; Restelli I; Cantoni C; Bresolin N; Monaco F; Scarpini E; Galimberti D
J Neurol Sci; 2009 Dec; 287(1-2):291-3. PubMed ID: 19683260
[TBL] [Abstract][Full Text] [Related]
16. A mutation in the 5'-UTR of GRN gene associated with frontotemporal lobar degeneration: phenotypic variability and possible pathogenetic mechanisms.
Puoti G; Lerza MC; Ferretti MG; Bugiani O; Tagliavini F; Rossi G
J Alzheimers Dis; 2014; 42(3):939-47. PubMed ID: 25024321
[TBL] [Abstract][Full Text] [Related]
17. Missense mutation in GRN gene affecting RNA splicing and plasma progranulin level in a family affected by frontotemporal lobar degeneration.
Luzzi S; Colleoni L; Corbetta P; Baldinelli S; Fiori C; Girelli F; Silvestrini M; Caroppo P; Giaccone G; Tagliavini F; Rossi G
Neurobiol Aging; 2017 Jun; 54():214.e1-214.e6. PubMed ID: 28285794
[TBL] [Abstract][Full Text] [Related]
18. A novel progranulin mutation causing frontotemporal lobar degeneration with heterogeneous phenotypic expression.
Rossi G; Piccoli E; Benussi L; Caso F; Redaelli V; Magnani G; Binetti G; Ghidoni R; Perani D; Giaccone G; Tagliavini F
J Alzheimers Dis; 2011; 23(1):7-12. PubMed ID: 20930271
[TBL] [Abstract][Full Text] [Related]
19. Progranulin gene (GRN) promoter methylation is increased in patients with sporadic frontotemporal lobar degeneration.
Galimberti D; D'Addario C; Dell'osso B; Fenoglio C; Marcone A; Cerami C; Cappa SF; Palazzo MC; Arosio B; Mari D; Maccarrone M; Bresolin N; Altamura AC; Scarpini E
Neurol Sci; 2013 Jun; 34(6):899-903. PubMed ID: 22797721
[TBL] [Abstract][Full Text] [Related]
20. New insights into biological markers of frontotemporal lobar degeneration spectrum.
Borroni B; Alberici A; Archetti S; Magnani E; Di Luca M; Padovani A
Curr Med Chem; 2010; 17(10):1002-9. PubMed ID: 20156164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
